Overview

Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
Single centre, open-label, multiple doses, two parallel study groups each receiving two formulations in a one-sequence design
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Eslicarbazepine acetate
Phenytoin